Contrary to startup culture, the best training for biotech leadership is gaining broad, cross-functional experience in a large, structured pharmaceutical company. This foundation provides the necessary depth and breadth to navigate the complexities of leading a smaller, resource-constrained biotech later on.

Jodie Morrison defines her role as a 'smoke jumper,' a leader brought in specifically to stabilize an organization during a leadership change or crisis. This is a distinct skillset focused on immediate stabilization and team alignment.

The transition from a leadership role at a large pharma company like Gilead to a biotech CEO involves a massive shift in scope. Instead of managing one large function with a large team, a biotech CEO is hands-on with every aspect of the company, from science to finance.

In the early stages, a biotech CEO's role is primarily scientific leadership and storytelling to attract investors. As the company and market mature, the role shifts. Effective CEOs must then become adaptable strategists, staying true to their core vision while responding to the dynamic industry environment.

Kevin Pojasek credits his effectiveness to a deliberate 12-year journey through diverse roles—investing, company creation, research, and clinical operations. This broad experience allows a leader to understand how all parts of the company, from high-level strategy to detailed science, fit together.

Adam Rogers became CEO of his first company, Hemera, not because he aspired to the title, but because he was the most committed person to drive the project forward. This shows how leadership can emerge organically from dedication and necessity in an early-stage venture, rather than a pre-defined career path.

To become a successful non-founder CEO, you need a holistic view of the business. Intentionally gain hands-on experience in every major function—sales, product, support, M&A—not just your area of expertise. This builds empathy and systemic understanding.

Investor preference for CEOs has shifted dramatically. While 2019-2021 favored scientific founder-CEOs, today’s tough market demands leaders with prior CEO experience. The ideal candidate has a "matrix organization" background, understanding all business functions, not just the science.

Biotech CEOs with business-only backgrounds often possess a crucial humility about their scientific limitations. This forces them to prioritize hiring exceptional R&D talent and empowering them to succeed, avoiding the trap of micromanagement.